Epsilon Healthcare Limited Share Price Other OTC
Equities
HDRPF
AU0000137598
Pharmaceuticals
Sales 2021 | 5.5M 3.66M 305M | Sales 2022 | 7.11M 4.74M 394M | Capitalization | 7.51M 5M 416M |
---|---|---|---|---|---|
Net income 2021 | -9M -5.99M -499M | Net income 2022 | -13M -8.66M -720M | EV / Sales 2021 | 3.26 x |
Net Debt 2021 | 2.1M 1.4M 117M | Net Debt 2022 | 2.34M 1.56M 130M | EV / Sales 2022 | 1.38 x |
P/E ratio 2021 |
-1.48
x | P/E ratio 2022 |
-0.38
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.39% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | 21/11 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 23/22/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Beasley
CHM | Chairman | - | 29/16/29 |
Stuart Cameron
BRD | Director/Board Member | - | 27/22/27 |
Xiao Cui
CHM | Chairman | - | 28/22/28 |
1st Jan change | Capi. | |
---|---|---|
+38.51% | 727B | |
+31.74% | 594B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.44% | 205B | |
-5.97% | 203B | |
+6.19% | 164B |